Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.

UC San Diego scientists have created a gene therapy that goes beyond masking Alzheimer’s symptoms—it may actually restore ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10 percent of people over the age of 65 and one third of people aged 85 and above. Besides environmental ...

R136S, or the “Christchurch mutation,” appears to protect against Alzheimer’s disease by suppressing inflammatory signaling ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

A study reveals that the APOE3-R136S mutation delays Alzheimer’s disease by inhibiting the cGAS-STING immune pathway. This ...

A groundbreaking study has revealed that a rare gene variant, APOE3-R136S, delays the onset of Alzheimer's disease by ...

South Carolina is creating a statewide network for researching and treating Alzheimer's disease even as advocates lobby for ...

Researchers at University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's disease ...